iOSAT vs ThyroSafe: Which FDA KI Tablet Should You Buy?
The only two FDA-approved potassium iodide tablets, head-to-head. We break down price, shelf life, dosing, and family use so you can choose with confidence.
The Verdict: For adults-only households: iOSAT. For families with kids: ThyroSafe. iOSAT wins on shelf life (10 years) and single-tablet adult dosing. ThyroSafe wins on pediatric convenience — no pill-splitting for kids 3-12.
Head-to-Head Comparison
| Category | iOSAT 130mg | ThyroSafe 65mg |
|---|---|---|
| Price (per tablet) | ~$1.00–$1.30 | ~$0.60–$0.75 |
| Shelf Life | 10 years | 6–7 years |
| Adult Dosing | 1 tablet (130mg) | 2 tablets (2×65mg) |
| Pediatric Dosing | Must split (65mg = ½ tablet) | 1 tablet (65mg) |
| Portability | 14 tablets, compact box | 20 tablets, blister packs |
Price Comparison
Let's talk numbers. A standard pack of iOSAT contains 14 tablets and typically costs $14–$18. That's roughly $1.00–$1.30 per tablet. ThyroSafe gives you 20 tablets for $12–$15, which works out to about $0.60–$0.75 per tablet. At first glance, ThyroSafe appears cheaper.
But there's a catch: adults need two ThyroSafe tablets to reach the 130mg adult dose. So while the per-tablet cost is lower, the per-dose cost for adults is roughly equivalent between the two products. Where ThyroSafe shines is pediatric dosing — kids ages 3–12 need exactly one 65mg tablet, so you're not paying for more medication than necessary.
For a family of four with two adults and two children (ages 3–12), a 14-day supply would require 28 iOSAT tablets (split for the kids) or 56 ThyroSafe tablets (2 per adult, 1 per child per day). The ThyroSafe route costs slightly more upfront but eliminates the hassle and potential error of splitting tablets under stress.
Both products occasionally sell out during geopolitical tensions or nuclear news cycles. When that happens, prices on third-party marketplaces can spike 50–100%. We recommend buying before you need it, not after headlines break.
Dosing Convenience
This is where the two products diverge significantly, and where your household composition should drive your decision.
iOSAT's 130mg strength is perfect for adults. One tablet, one dose, no math. The tablets are cross-scored, meaning they have X-shaped cuts that allow you to split them into halves (65mg) or quarters (32.5mg). This works reasonably well for children 3–12 who need 65mg, and for infants who need smaller fractions using the FDA crushing protocol.
But here's the reality: splitting a small pill accurately while stressed, possibly in dim lighting, possibly while your hands are shaking, is not ideal. The quarter-tablets from iOSAT give you 32.5mg, which is close to the 32mg dose for children 1 month to 3 years. But it's not exact, and precision matters when you're dealing with radiation protection.
ThyroSafe eliminates this friction entirely for kids 3–12. One tablet = perfect dose. The cross-scoring still allows quartering (16.25mg) for infant dosing if needed. Adults simply take two tablets. Yes, that's twice as many pills to manage, but the trade-off is worth it for many families.
Our recommendation: if you have children ages 3–12, ThyroSafe is the safer, simpler choice. If your household is adults only, iOSAT's single-tablet dosing wins.
Shelf Life Differences
Shelf life is iOSAT's biggest advantage. Anbex, iOSAT's manufacturer, has been producing FDA-approved KI tablets since 1982. They have decades of stability data supporting their 10-year expiration claim. Buy a pack today, mark your calendar for 2036, and forget about it.
ThyroSafe carries a 6–7 year shelf life. This isn't a quality issue — Recipharm/BTG simply hasn't submitted the same longitudinal stability data to the FDA. The tablets are just as stable; the difference is regulatory. The FDA approves shelf lives based on manufacturer-submitted data, and Anbex has simply been at this longer.
Is 6–7 years "short"? Not really. You're looking at replacing your supply once a decade instead of once every ten years. For most families, that's manageable. Set a phone reminder for six years out and replace your stock when it pings.
Both products use individually foil-sealed blister packs that protect against moisture and light. We've seen packs that sat in emergency kits for years open up looking exactly like they did on day one. Store either product at room temperature away from humidity, and they'll last their stated shelf life.
Trust & Factory Quality
Both iOSAT and ThyroSafe are FDA-approved drugs, not supplements. That means both meet the same rigorous standards for purity, potency, and manufacturing consistency (cGMP). Both are validated through the FDA's drug approval process, not the looser supplement regulations.
iOSAT is manufactured by Anbex, Inc., a Virginia-based company that has supplied potassium iodide to the Department of Homeland Security, Department of Defense, and state emergency management agencies for over four decades. When the U.S. government stockpiles KI for nuclear emergencies, this is what they buy. The NDC 51803-001 tablets you purchase are identical to those in government stockpiles.
ThyroSafe is manufactured by Recipharm (now part of BTG International), a Swedish pharmaceutical company with global manufacturing facilities. Their NDC 67653-001 tablets have the same FDA approval status as iOSAT. The manufacturing happens in FDA-inspected facilities to the same standards.
Both products contain lactose monohydrate as an inactive ingredient. If you have severe lactose intolerance or milk protein allergies, consult your doctor. For lactose-free options, consider the FDA-approved ThyroShield Oral Solution or KI supplements that use different fillers.
The bottom line: both products are trustworthy. You can't go wrong with either from a quality perspective. Your choice should be based on dosing convenience and shelf life preferences, not regulatory status.
The Call
Choose iOSAT if you're adults-only and want maximum shelf life with minimum pill management. Choose ThyroSafe if you have kids ages 3–12 and want stress-free pediatric dosing.
Many smart families buy both: iOSAT for the parents (10-year shelf life, one tablet), ThyroSafe for the kids (perfect 65mg dose, no splitting).
Check iOSAT Price →Frequently Asked Questions
Which is better: iOSAT or ThyroSafe?
For adults-only households, iOSAT is better due to its 10-year shelf life and single-tablet adult dosing. For families with children ages 3-12, ThyroSafe is better because the 65mg tablets eliminate the need to split pills for kids.
Can I take ThyroSafe if I'm an adult?
Yes. Adults simply take two 65mg tablets to reach the 130mg adult dose. The FDA considers this equivalent to taking one 130mg tablet. The only downside is managing two pills instead of one during an already stressful situation.
Is iOSAT more expensive than ThyroSafe?
Yes, per tablet. iOSAT costs approximately $1.00–$1.30 per tablet, while ThyroSafe costs about $0.60–$0.75 per tablet. However, ThyroSafe requires adults to take two tablets, making the per-dose cost similar. The real savings with ThyroSafe come for families with children who need the 65mg pediatric dose.
Do both products have the same FDA approval?
Yes. Both iOSAT 130mg (NDC 51803-001) and ThyroSafe 65mg (NDC 67653-001) are FDA-approved potassium iodide products. They meet the same manufacturing standards for purity, potency, and stability. Both are drugs, not supplements, and both are held to pharmaceutical-grade cGMP standards.
Can I split iOSAT tablets for my children?
Yes, iOSAT tablets are cross-scored and can be split into halves (65mg) or quarters (32.5mg). However, splitting tablets accurately during an emergency adds stress and risk of dosing errors. For families with children ages 3-12, ThyroSafe 65mg tablets are recommended as they require no splitting — just hand your child one tablet and water.
Should I buy both iOSAT and ThyroSafe?
Many families choose to stock both: iOSAT 130mg for adults (one tablet per person) and ThyroSafe 65mg for children ages 3-12 (one tablet per child). This approach maximizes convenience while maintaining FDA-approved quality for everyone in the household. It's the solution we recommend for families who want the best of both worlds.